POUlhomeobox
genes encode transcription regulatory proteins that are important in defining cellular phenotypes.
Expression of these genes may be critical for to the regulation of CNS cellular differentiation.
We have identified a cDNA corresponding to a new member of the POU/homeobox gene family. Expression of RNA encoded by this new gene occurs predominantly in the CNS. Thus, this new gene was designated Cns-7. Cns-7 transcripts are expressed in differentiating cells cultured from the early postnatal cerebellum. Treatment of these cultured cells with NMDA results, in an increase in the level of Cns-7 RNA. This increase is blocked by simultaneous treatment with the specific NMDA receptor antagonist amino&phosphonovaleric acid. Continued activation of the NMDA receptor allows maintenance of this new steady state level of Cns-7 mRNA for at least 5 d in these cultured cells. A transcription runoff assay suggests that this increase in the level of RNA is due, at least in part, to an increase in transcription from the Cns-7 gene. The NMDA-induced increase in Cns-7 mRNA was reduced by pretreatment with calcium chelators EGTA or 1,2-bis(2-aminophenoxy)ethane-N,f+!,,N,N-tetraacetic acid (BAPTA) tetrakis(acetoxymethyl).
These studies suggest that specific activation of the NMDA receptor in cultures of differentiating cerebellar cells increases Cns-7 gene expression and that calcium entry through the NMDA channel may be required for this response.
This The mammalian CNS contains a precisely integrated network of many distinct cellular phenotypes. During CNS development these diverse cell types arise from multipotent precursor cells present in the neural tube. Clonal analysis of CNS precursors suggests that, even up to their final cell division, an individual precursor can give rise to multiple cell types (Turner and Cepko, 1987; Luskin et al., 1988; Wetts and Fraser, 1988; Walsh and Cepko, 1992) . It is likely that the specification of individual cell fates requires local interactions involving environmental signals (Kessler, 1986; Adler and Hatlee, 1989; Iacovitti et al., 1989; McConnell and Kaznowski, 199 1) . These instructive signals direct the expression of specific genes that are ultimately responsible for defining particular cell fates. Homeobox genes may be important components in this process. These genes encode transcription regulatory proteins that are likely to function in combination with other transcription factors to specify individual CNS cellular phenotypes (He and Rosenfeld, 199 1) . Homeobox genes have been well characterized in invertebrates, where their protein products function as key regulators of transcription involved in controlling development and defining cellular phenotypes (Akam, 1987; Scott and Carroll, 1987; Doe et al., 1988a,b; Finney et al., 1988; Ingham, 1988; Way and Chalfie, 1989) . In mammals, the expression of homeobox genes occurs in both CNS precursors and mature CNS cell populations. The Hox genes (Kessel and Gruss, 1990) several POU/homeobox genes (He et al., 1989) , Pax-3 (Goulding et al., 1991) , Tes-I (Porteus et al., 1991) and Nkx-2.2 (Price et al., 1992) are expressed in cells within spatially restricted regions of the developing neural tube. In the adult nervous system Hox 1.3 and the POU/homeobox genes Brn-I, Brn-2, Tst-I, Ott-I, and Ott-2 are expressed in distinct but overlapping populations of mature CNS cells (Odenwald et al., 1987; He et al., 1989) . This distinct distribution of gene expression suggests that homeobox genes may also regulate the differentiation of individual mammalian CNS cellular phenotypes. In the developing CNS instructive signals may define individual cellular phenotypes through control of the expression of particular homeobox genes. Cells cultured from the early postnatal cerebellum may provide a useful system for studying the effect of instructive signals on the differentiation ofan individual CNS neuronal phenotype. These postnatal cerebellar cultures contain cerebellar granule neurons and their precursors, other cerebellar interneurons, and cerebellar glia (Trenkner, 199 1) . Some aspects of the development and differentiation of granule neurons occur in these postnatal cerebellar cultures and can be modified by the addition of extracellular factors (Balazs et al., 1988a; Hatten et al., 1988; Kingsbury et al., 1989; Messer, 1989; Gao et al., 199 1; Trenkner, 199 1) . We are interested in learning whether conditions that modify differentiation ofthese cells also alter expression of identified homeobox genes. Several studies report that activation of NMDA receptors in cultured cerebellar granule neurons can modify neurite outgrowth (Pearce et al., 1987; Cambray-Deakin and Burgoyne, 1992) survival (Balbzs et al., 1988a,b) , differentiation (Moran and Patel, 1989; Cox et al., 1990) , and migration (Komuro and Rakic, 1992 ) of these cells. NMDA receptor activation also appears to mediate trophic responses in other CNS neurons and may regulate activity-dependent development of certain populations of CNS neurons (Kleinschmidt et al., 1987; Lipton and Kater, 1989; Scherer and Udin, 1989; Cline and Constantine-Paton, 1990; Kalb and Hockfield, 1990; Cline, 199 1; Simon et al., 1992) . Studies have also shown that spontaneously active NMDA receptors are present in the early developing CNS (Blanton et al., 1990; Lo Turco et al., 199 1; Kalb et al., 1992) . One mechanism by which NMDA receptor activation could control these developmental events is through the regulation of expression of particular homeobox genes.
In 
Materials and Methods
Identification of POWhomeobox sequences by PCR. Total RNA was prepared from adult mouse cerebella using previously described methods (Chomczynski and Sacchi, 1987) . PolyA+ RNA was isolated by chromatography on oligo-dT cellulose as described by Sambrook et al. (1989) . We synthesized the first strand of cDNAs using polyA+ RNA primed with random hexamers and Moloney murine leukemia virus reverse transcriptase (U.S. Biochemicals, Cleveland, OH). Amplification by the polymerase chain reaction (PCR) was accomplished by the addition of polymerase buffer (50 mM KCl, 20 mM Tris pH 8.4, 2.5 mM M&l,, and-160 &ml BSA), dNTPs, primers, and Taq DNA polymerase (U.S. Biochemicals) to the cDNA. The cycling progression involved denaturation for 2 min at 94°C primer annealing for 2 min at 58°C and primer extension for 3 min at 72°C. We repeated this cycling uroeression 35 times with the last 72°C incubation lasting 15 min. The primers used for PCR were degenerate oligonucleotides representing all possible codons for two regions of conserved amino acid sequence in eight POU/homeodomain proteins (He et al., 1989) . The upstream primer was from a conserved region in the POU-B domain, T/S-T-I-C/S-R-F-E, and the downstream primer was from a conserved region in the homeodomain, V-I/V-R-V-W-F-C-N (see Fig. 2 ). We had the upstream primer synthesized with a 5' EcoRI restriction site and the downstream primer with a 5' XbaI restriction site. Following PCR amplification DNA products were separated on a 1% agarose gel and stained with ethidium bromide. The DNA bands migrating to a position corresponding to 320-350 base pairs (bp) (expected size of POU/homeobox sequences based on the position of the primers) were purified as a single pool. We digested this DNA with EcoRI and XbaI, and ligated into the EcoRI-XbaI sites of the pGEM7Z vector. This DNA was used to transform Escherichia co/i. Individual clones were isolated and the plasmid DNA purified for DNA sequence analysis (Sanger et al., 1977) .
Isolation of Cns-1 cDNAs. We synthesized a random-primed DNA probe from the PCR clone PCRPH3. This probe was used to screen an amplified adult C57Bl/6J mouse brain XgtlO cDNA library (obtained from D. R. Burt, University of Maryland School of Medicine). We transferred 6 x 10s recombinants from this library to nitrocellulose filters by standard procedures (Sambrook et al., 1989) . Filters were prehybridized for 2-4 hr at 42°C in H buffer containing 5.6~ SSPE (0.84 M NaCl, 64 mM Na,PO,, 6 mM EDTA), 50% formamide, 5~ Denhardt's solution (0.1% ficoll, 0.1% polyvinylpyrrolidone, 0.1% bovine serum albumin), 1% SDS, and 200 pg/rnl tRNA. We preformed hybridizations in H buffer containing l-3 x lo6 cpm/ml of PCRPHS orobe fsnecific activitv of l-2 x lo9 cornlug) for.48 hr at 42°C. Filters were washed under high-stringency conditions [O. 1 x SSC (15 mM NaCl, 1.5 mM sodium citrate), 1% SDS at 65"C] and exposed to Kodak RP x-ray film. We purified 10 positive clones and determined the cDNA insert size by restriction enzyme analysis. The longest clone (PH3,1-2) contained an insert of -4.6 kilobases (kb). The insert was subcloned into the plasmid pBluescript (Stratagene, La Jolla, CA) for restriction mapping and sequence analysis. We generated subclones for sequence analysis by restriction enzyme and exonuclease III digestion (Henikoff, 1984) . We used double-stranded plasmid DNA for sequence analysis of both DNA strands (Sanger et al., 1977) . The GenBank accession number for the Cns-I cDNA sequence is L13763.
Cell cultures from the early postnatal cerebellum. Cells from the cerebellum of postnatal day 7 (P7) CD-l mice were dissociated into a single-cell suspension by previously described methods (Kingsbury et al., 1989) ; l-2 x 10' cells were plated on 35 mm netri dishes in a chemically defined medium composed of minimal essential medium (without glutamic acid and glycine) containing 6 m&ml glucose, 10 ~Lgl ml bovine serum albumin (Sigma, St. Louis, MO), 200 fig/ml human transferrin (Sigma), 32 fig/ml putrescine (Sigma), 10 &ml sodium selenite (Sigma), 10 bg/rnl insulin (Sigma), 1.25 &ml progesterone (Sigma), 20 t&ml triiodothyronine (Sigma), 4 rig/ml corticosterone (Sigma), 2 mM glutamine (Sigma), and 100 &ml gentamicin (GIBCO/Bethesda Research Labs, Gaithersburg, MD). This medium allows extended survival of cultured neurons without NMDA or depolarizing concentrations of KC1 (Cox et al., 1990) . The cultures were maintained for 24 hr at 37°C in 5% COz. Under these conditions the cells formed large aggregates with bundles of interconnecting cell processes similar to cerebellar cultures describes previously (Trenkner, 1991) . After 24 hr of culture we added KC1 to each culture to bring the final concentration to 10 mM. Cultures were then treated with 10 PM glycine (Sigma), 20 FM 6-cyano-7-nitroquinoxaline-2,3-dione (CNOX: Cambridae Research Biochemicals), 100 PM amino-5-phosphonbvaleric acid?APV; Sigma), 0.1-200 PM N-methyl-D-aspartate (NMDA; Sigma), 10 PM y-aminobutyric acid (GABA; Sigma), 10 PM somatostatin (Calbiochem, San Diego, CA), and/or basic fibroblast growth factor (Calbiochem). We added these compounds directly to the culture medium. Incubation of cultures was continued for O-24 hr at 37°C in 5% CO,. We treated some cultures containing 10 mM KC1 and 10 FM glycine for 2 hr with 4 or 8 mM MgSO,, 1.5 or 2.5 mM ethylene glycol-his@-aminoethyl ether) N, N, N', N',-tetraacetic acid (EGTA; Sigma) or 20 FM 1,2-bis(2-aminophenoxy)ethane-N, N, N', N'-tetraacetic acid (BAPTA) tetrakis(acetoxymethy1) ester (Molecular Probes, Eugene, OR). We added NMDA (50 PM) directly to the culture medium following pretreatment of cells with Mg*+ or EGTA. After BAPTA pretreatment we removed the BAPTA-containing medium from cells and replaced with the fresh chemically defined medium, minus BAPTA, containing 50 PM NMDA. These cultures were then incubated for an additional 24 hr. The viability of cultured cells following these various treatment conditions was determined by trypan blue exclusion. Cells are loosely attach to the petri dish and can be removed and dissociated by trituration through a Dinette tip. After dissociation, cell viability was determine by incubating-cells in 0.08% trypan blue in PBS. Cells that excluded the dye and those that incorporated the dye were counted using a hemocytometer. Viability was expressed as the percentage of total cells that excluded the dye.
RNA blot analysis. We prepared total RNA from adult mouse tissues or from cultured cells using previously described methods (Chomczynski and Sacchi, 1987) . We separated total RNA (20 pg) from individual adult tissues or cultured cells by formaldehyde agarose gel electrophoresis (Sambrook et al., 1989) . The gels were stained with ethidium bromide and the RNA visualized under UV light to confirm that similar amounts of RNA were loaded in each lane of the gel. We transferred the RNA to nylon membranes (Stratagene, La Jolla, CA) by standard capillary transfer (Sambrook et al., 1989) . RNA was cross-linked to membranes using a UV cross-linker (Stratagene, La Jolla, CA). We hybridized RNA blots with a cDNA probe synthesized bv random oriming from a 3.7 kb EcoRI-Hind111 fragment of PH3,1-2. RNA blots were prehybridized for 2-4 hr at 42°C in H buffer (as described above). Hybridization was accomplished in H buffer containing l-3 x lo6 cpm/ ml of probe (specific activity of l-2 x 10' cpm/pg) for 48-72 hr at 42°C. Blots were washed under high-stringency conditions (0.1 x SSC, 1% SDS at 65°C) and exposed to Kodak AR x-ray film for l-3 d. After x-ray film exposure the probe was removed from blots by incubation in 25 mM Tris pH 7.5, 0.5 x Denhardt's (0.0 1% ficoll, 0.0 1% polyvinylpyrrolidone, 0.01% BSA), 0.1% SDS for 30 min at 85°C. We hybridized the same blots under conditions described above with a probe synthesized from a 3 kb EcoRI fragment of an En-2 cDNA obtained from A. L. Joyner, Mt. Sinai Hospital Research Institute, University ofToronto. Probes synthesized from other cDNAs were also used to rehybridize blots:, an Ott-1 cDNA was obtained from W. The open reading frame begins with an ATG that is consistent with Kozak's criteria for an initiation codon (Kozak, 1986 (Kozak, , 1991 . The predicted amino acid sequence of Cns-1 contains a POU-specific domain, a homeodomain, and a domain rich in serine, threonine, and proline residues. These domains are shown by the boxed sequences. The GenBank accession number for the Cns-I cDNA sequence is L13763.
Laboratory; SCIP/Tst-1 and Cer-1 cDNAs were isolated in our laboratory (R. F. Bulleit, unpublished observations). Repeated stripping of probes from blots reduced subsequent hybridization signals so that film exposure times frequently increased and varied from 2 to 12 d. Each experiment using cultured cells was repeated at least two times and the results of RNA blot analysis were consistently replicated in repeated experiments.
Nuclear runoftranscription assay. We measured transcriptional activity by isolating nuclei from cells (-3 x 10' cells) cultured in the presence or absence of 50 PM NMDA or 100 FM APV. Cells were lysed in 10 mM Tris-HCl pH 7.4, 10 mM NaCl, 3 mM MgCl,, 5% NP40, and nuclei were prepared as previously described (Greenberg and Ziff, 1984) . In vitro nuclear transcription was carried out in the presence of ribonucleotides and j2P-UTP at 30°C for 30 min (Greenberg and Ziff, 1984) . We isolated labeled RNA by methods described previously (Groudine et al., 198 1) . Labeled transcripts produced in this manner were hybridized in 6 x SSC, 5 x Denhardt's, 1% SDS, 200 pg/rnl tRNA at 65°C for 36-48 hr to DNA immobilized on nitrocellulose filters. We hybridized each filter with an equal number of cpm and washed filters under stringent conditions (0.1 x SSC, 1% SDS at 65°C). The filters were exposed to Kodak AR x-ray film for 5 d. Nitrocellulose filters were prepared using plasmid DNA (10 fig Figure   2 . The predicted amino acid sequence of Cm-1 is similar to other POU/homeodomain proteins in the POU-specific domain and the homeodomain. All amino acid sequence information except that for Bm-4 and Cns-1 was as reported by Rosenfeld (199 1) The amino acid sequence for Bm-4 was as reported by Le Moine and Young (1992) . The amino acid sequence for Cns-1 is as reported in this publication. The sequences are grouped into six classes based on relative sequence similarity. A dash indicates identity of amino acid sequence with Ott-1. The solid black bars identify the position of the sequences used in designing PCR primers. Regions with a-helical structure are indicated as Helix A and Helix B in the POU-specific domain and He/ix 1, 2, and 3 in the homeodomain. natured in 0.2 M NaOH for 30 min at room temperature followed by neutralization in 10 vol of 6 x SSC. We immobilized the DNA on nitrocellulose filters using a slot blot apparatus (Bio-Rad, Richmond, CA). Filters were baked for 2 hr at 80°C. The plasmid DNAs used in these experiments included a plasmid containing a 3.7 kb fragment of the Cns-I cDNA, a plasmid containing a 3 kb fragment of the En-2 cDNA, and a control plasmid, pGEM 11 Z.
Densitometry. Densitometry (Molecular Dynamics densitometer, Sunnyvale, CA) of exposed x-ray films was used to quantitate the hybridization signals on RNA blots hybridized with Cns-I and En-2 probes and in nuclear runoff transcription assays. Densitometric measurements (optical density, OD) were made on autoradiographs of RNA blots from three separate experiments in which cells were treated with glutamate receptor agonists of antagonists (see Fig. 4 ) or from three separate nuclear runoff transcription experiments (see Fig. 9 ). Background OD values were determined on each blot and subtracted from OD values for Cns-I and En-2 hybridization signals. We recorded the mean OD values * standard error of the mean for both Cns-1 and En-2 hybridization signals in RNA from cells treated under different conditions. Statistical analysis of the difference between the mean OD values for different treatment conditions was accomplished using a t test. We observed that the level of the hybridization signal for En-2 RNA didn't significantly change with any of the treatment conditions and was directly proportional to the level of 28s and 18s RNAs as visualized by ethidium staining of the RNA gels. Thus, En-2 can provide a reasonable measure of the relative amount of RNA on each blot.
Results
Isolation of Cm-1 cDNA clones Reverse transcription of cerebellar RNA in combination with the PCR allowed identification POU/homeobox genes expressed in the cerebellum. PCR was accomplished using degenerate oligonucleotide primers representing all possible codons for two conserved regions (Fig. 2) . PCR amplification yielded DNA fragments within the expected size range based on the position of the two primers. These PCR products were subcloned and individual clones were isolated and sequenced. Several different POU/homeobox cDNA clones were identified using this PCR protocol. The deduced amino acid sequence of one of these Regulates Expression of POU Gene Cm-1 28s -18s - clones (PCRPH3) suggested it encoded a new member of the POU/homeodomain protein family. We used a probe synthesized from the PCRPH3 clone to isolate full-length cDNAs from a mouse brain Xgt 10 cDNA library. We isolated 10 clones that contained overlapping restriction maps. The largest clone (PH3,1-2) contained an insert of -4.6 kb. Sequence analysis of this clone revealed an open reading frame beginning with an ATG that is consistent with Kozak's criteria for an initiation codon (Kozak, 1986, 199 1) . The open reading frame is 903 base pairs long and encodes a 301 amino acid protein with a molecular weight of 32,850 (Fig. 1) . This amino acid sequence contains regions that are similar but not identical to the POU-specific domain and the homeodomain of other POU/homeodomain proteins (Figs. 1, 2) . We have designated this new sequence Cns-1. An amino acid sequence comparison of the POU-specific domain and the homeodomain of Cns-1 and 13 other POU/homeodomain proteins is presented in Figure 2 . Cns-I is 48-57% identical to the other POU/homeodomain proteins within the POU-specific domain and 43-52% identical within the homeodomain. The greatest similarity was observed between Cns-1 and Pit-l, where there was 57% identity in the POU-specific domain and 52% identity in the homeodomain. Cns-1 and Pit-1 also have similar secondary structural features. Prediction of secondary structure in Cns-1 (Chou and Fasman, 1978) suggests that within the POU-specific domain and the homeodomain there are five a-helical regions. In the POU-specific domain one helical domain resides in each of the POU subdomains (POU-A and POU-B) and three helical domains are present in the homeodomain (Fig. 2) . The position of these helical domains is similar to the position of predicted helices in Pit-l (Ingraham et al., 1990) . We also observed that within the amino-terminal half of Cns-1 is a region rich in serine, threonine, and proline residues (Fig. 1) . This domain consists of 25% serine and threonine residues and 21% proline residues. Similar regions rich in serine and threonine residues are also present in the POUI homeodomain proteins Pit-1 and Ott-2 (Ingraham et al., 1990; Tanaka and Herr, 1990) .
Cns-1 is expressed in the CNS We examined the tissue distribution of Cm-1 mRNA. Total RNA was isolated from different adult brain regions and other tissues. We did RNA blot analysis under high-stringency conditions using a DNA probe synthesized from the Cns-I cDNA clone PH3,1-2. Under these conditions the probe hybridized to an -5 kb transcript (Fig. 3) . This transcript was present in all regions of the CNS examined (forebrain, midbrain, hindbrain, cerebellum, and spinal cord). We also observed hybridization to RNA of the same size in RNA isolated from kidney tissue. We detected only faint hybridization signals in the other tissues examined (heart, lung, liver, spleen, and intestine). Thus, Cns-1 mRNA is expressed predominantly although not exclusively in the CNS. We have also observed that Cns-I RNA is expressed in the developing postnatal cerebellum (Pl-P2 1; data not shown). A comprehensive evaluation of the developmental expression of Cns-I in the CNS is currently under way.
Expression of Cns-1 is modulated by activation of NMDA receptors in cells cultured from the early postnatal cerebellum Cultured established from the early postnatal cerebellum contain cerebellar granule cells and their precursors, other cerebellar interneurons, and cerebellar glia (Trenkner, 1991) . Cells were cultured at high density in a chemically defined medium that allows extended survival of these cells without depolarizing concentrations of KC1 (Cox et al., 1990) . We cultured cells for 24 hr before the addition of glutamate receptor agonists and/or antagonists. RNA blot analysis shows that Cns-1 mRNA is expressed in cultures under all treatment conditions (Fig. 4A) . The Cns-I probe hybridized to two different-sized transcripts (Fig. 4A) . The smaller of the two RNAs was the same size as the prominent Cns-I transcript observed in adult tissues (Fig.  3) . This larger RNA was also observed in adult tissues if blots were exposed for longer periods of time (data not shown). Since all of the RNA blots were washed at high stringency, this larger RNA must be a transcript from a very closely related gene, a splicing variant of the Cns-I transcript or derived from the use of an alternate polyadenylation signal. An RNase protection experiment suggested that RNA from cultured cells could fully protect a 300 bp RNA fragment synthesized from the Cns-I cDNA. We observed no other partially protected fragments (data not shown). This observation suggests that the observed transcripts on RNA blots are likely to be derived from the Cns-1 gene. However, further studies are necessary to determine which of several possibilities might account for the larger transcript.
The level of these Cns-I mRNAs changed in response to treatment with NMDA receptor agonists and antagonists. Treatment of cultures with glycine (10 PM), which potentiates agonist response at the NMDA receptor (Johnson and Ascher, 1987) or 20 PM CNQX, a non-NMDA glutamate receptor antagonist, did not result in a significant difference in the level of Cns-1 RNA when compared to control cultures (Fig. 4A, lanes l-3) . Treatment with 100 PM APV, a competitive antagonist at the NMDA receptor, appeared to reduced the level of Cns-1 RNA when compared to treatment with 10 mM KC1 (Fig. 4A, Cm-1 mRNA (Fig. 4A, lane 7) . However, CNQX did not affect this increase (Fig. 4A, lane 6) . A comparison of the mean OD measurements from blots of three separate experiments showed that treatment of cells with NMDA or NMDA plus CNQX resulted in a 2.8-3.3-fold increase in the level of Cm-1 mRNA when compared to APV-treated cultures and a 2.2-2.6-fold increase when compared to control cultures. These differences were statistically significant at p values < 0.03. We observed a similar increase in the level of the larger Cm-1 transcript following NMDA treatment. Treatment of these cultures with 20 PM glutamate also resulted in an increase in the level of Cns-1 mRNA that was blocked by cotreatment with APV (data not shown). We remove the Cns-I probe from the blots and rehybridized the blots with a probe to the homeobox gene En-2 to determine if the levels of other homeobox gene transcripts were also increase in response to NMDA treatment. Densitometric measurements of the En-2 hybridization signals showed that there was no significant change in the level of En-2 RNA following treatment with any of NMDA receptor agonists or antagonists (Fig. 4B) . Thus, NMDA treatment does not result in a general increase in the level of all homeobox gene transcripts.
We also observed that the changes in the level of En-2 RNA were consistent with changes in the level of RNAs as measured by absorbance at 260 nm and visualization by ethidium staining of the RNA gels (Fig. 4C) . Thus, the En-2 hybridization signal provides a measure of the relative amount of RNA in each lane of the blot and suggests that the increase in Cns-I mRNA is not the result of differences in the level of total RNA on the blots. Examination of RNAs encoded by several other homeobox genes suggested that the levels of mRNA for these genes were, for the most part, not altered by treatment with NMDA (Fig. 5) . RNAs encoding En-2, the POU/homeobox gene Oct-1, and a newly identified homeobox gene related to the Drosophila paired gene, Cer-I (Bulleit, unpublished observations), are expressed at similar levels under all treatment conditions (Fig. 5) . The exception was RNA encoded by the POU/homeobox gene SUP (Monuki et al., 1989 ; also referred to as Tst-I or Ott-6), which also appeared to increase in response to NMDA treatment, but to a lesser degree than Cns-I mRNA. Thus, NMDA receptor activation specifically results in an increase in transcripts for the Cns-1 gene and possibly the SCIP/Tst-1 gene.
NMDA caused a dose-dependent increase in the level of the Cns-I mRNA. We observed a response at concentrations of t partate (NMDA). A, RNA blot analysis using an Cns-I cDNA probe was accomplished as described in Figure 3 and Materials and Methods. The mean OD f SE from densitometric measurements of the autoradiographs of three separate blots is presented along with a representative autoradiographic image. The asterisks (*) indicate that these mean OD values are statistically different (P < 0.03) than the mean OD values for any of the other treatment conditions. B, The &s-I probe was removed from the blots and the blots were hybridized with an En-2 cDNA probe (refer to Materials and Methods). The mean OD f SE of the hybridization signals is presented along with the autoradiographic image from the same blot presented in A. C, Ethidium bromide staining of the RNA gel used for blot analysis to obtain the autoradiographic image presented in A and B. Cer-1 Figure 5 . NMDA receptor activation does not affect the expression of several homeobox gene transcripts in cultured cerebellar cells, Cells from the early postnatal cerebellum were cultured for 24 hr in a chemically defined medium containing 5 mM KCl. Cultures were continued for an additional 24 hr in medium containing 10 mM KC1 and 10 WM glycine plus (+) 20 PM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), 100 PM amino-Sphosphonovaleric acid (APJ'), and/or 50 PM N-methyl-D-aspartate (NA4LI.4). RNA blot analysis using an Cns-I cDNA probe was accomplished as described in Figure 3 and Materials and Methods. Probes to several other homeobox genes (En-2,Oct-1, SCIP/Tst-I, and Cer-I) were used for repeated rehybridization to the same blot (refer to Materials and Methods).
NMDA as low as 10 PM, reaching a peak at 50-l 00 PM NMDA (Fig. 6A) . The increase was also apparent in cells treated with NMDA in physiologic magnesium (5 mM) without added glycine (Fig. 7) . High concentrations of KC1 (40 mM) also resulted in an increase in Cns-I transcript levels (Fig. 7) . Treatment of cells with GABA, somatostatin, or basic fibroblast growth factor did not affect the level of Cm-1 RNA (Fig. 7) although cultured granule cells express functional receptors for all three of these ligands (Hatten et al., 1988; Bovolin et al., 1992; Gonzalez et al., 1992 ). An increase in the level of this mRNA was first apparent -2 hr after the start of NMDA treatment (Fig. 6B) . The level of mRNA continued to increase up to 24 hr following NMDA treatment (Fig. 6B ). This increase in the level of Cm-1 mRNA could be maintained for at least 5 d (Fig. 8) . APV added after 4 d of NMDA treatment reduced the level of Cns-I mRNA to control levels over the next 24 hr of culture (Fig. 8) . The above data suggest that the specific activation of the NMDA receptor results in an increase in the level of Cns-1 mRNA and that the maintenance of this increased mRNA level requires that this receptor remain active. The results of experiments described above suggest that activation of NMDA receptors in cultures of early postnatal cerebellar cells result in a specific increase in the level of Cns-I RNA blot analysis using an &s-I cDNA probe was accomplished as described in Figure 3 and Materials and Methods.
mRNA. This increase in the steady state mRNA level could be the result of an increase in transcript synthesis or a decrease in transcript degradation. We measured the level of transcript synthesis using isolated nuclei from cultured cerebellar cells that had been treated with either APV or NMDA. A nuclear runoff transcription assay was used to measure the level of transcription from both the Cns-I and En-2 genes (Greenberg and Ziff, 1984) . Nuclei isolated from cultured cells after 24 hr of treatment with NMDA exhibited a 1.6-fold increase in transcription from the Cm-1 gene when compared to nuclei of cells treated with APV (Fig. 9 ). These observations suggest that the NMDA induced change in Cns-I mRNA level is at least in part the result of an increase in the rate of transcription from the Cns-I gene. However, we cannot rule out that a change in the rate of transcript degradation is also partially involved in mediating this response since the increase in the level of transcription is not identical to the increase in the level of &s-I RNA.
Calcium mediates the increase in the level of Cns-1 RNA in response. to NMDA treatment
The NMDA receptor is a ligand-gated ion channel that when opened allows cations to move across the cell membrane, including Ca2+. At physiologic Mg*+ concentrations there is a voltage-dependent Mg*+ block of the NMDA channel (Mayer et al., 1984) . Depolarizing conditions release Mg2+ from the channel allowing Ca2+ to enter the cell. High Mg2+ concentrations will antagonize NMDA receptor activation by blocking the channel. Treatment of cultured cerebellar cells with high Mg*+ concentrations (4 mM) consistently reduced the increase in Cns-I mRNA in response to NMDA treatment (Fig. 10) . Although higher concentrations of Mg2+ (8 mM) didn't reduce the viability of cultured cells (Fig. 1 l) , they did alter the mor- Thus, we didn't use higher concentration of Mg2+ in these experiments. The incomplete block by 4 mM Mg*+ may' result from a reduced sensitivity of the NMDA receptor to MgZ+ in developing neurons (Bowe and Nadler, 1990; Morrisett et al., 1990) . However, the observation that 4 mM Mg*+ could reduce the NMDA response suggests that an open NMDA receptor/ channel is required to induce the change in Cm-1 transcript levels. We also used Ca*+ chelators to determine if Ca*+ entry through the NMDA channel mediates the increase in the level of Cns-I RNA. Treatment of cells with 1.5 mM EGTA, a chelator of extracellular Ca2+, reduced the NMDA mediated increase in Cm-1 mRNA (Fig. 10) . A membrane-permeant form of BAPTA (BAPTA acetoxymethyl ester) was used as an intracellular chelator of Ca2+. Cells were pretreated for 2 hr with BAPTA and the BAPTA containing medium was removed before exposure to NMDA. Conversion of the BAPTA analog to the parent acid occurs inside the cell sequestering it inside the cellular compartment. Treatment with these calcium chelators reduced the level of Cm-1 mRNA in response to NMDA (Fig.  10) . The level of En-2 RNA was the same under all these treatment conditions (data not shown). Thus, chelation of either extracellular and intracellular calcium reduced the response of Cns-1 5 mM KC1 (5d) 50 I.IM NMDA (5d) 100 /.hM APV (Id) Figure 8 . The maintenance of an increase in Cns-1 mRNA is dependent on the continued activation of the NMDA receptor. Cells from the early postnatal cerebellum were cultured for.5 d in a chemically defined medium containing (+) 5 mM potassium chloride (KCY), 5 mM KC1 plus 50 PM N-methyl-D-aspartate (NMDA), or 5 mM KC1 plus 50 PM NMDA in which 100 PM amino-5-phosphonovaleric acid (API") was added for the last 24 hr. RNA blot analysis using an Cns-I cDNA probe was accomplished as described in Figure 3 and Materials and Methods. Figure 7 . Treatment of cultured cerebellar cells with both NMDA and high concentrations of KC1 results in an increase in the level of Cns-I mRNA. Cells from the early postnatal cerebellum were cultured for 24 hr in a chemically defined medium containing 5 mM KCl. Cultures were continued for an additional 24 hr in medium containing 5 mM potassium chloride (KC!) plus 10 PM y-aminobutyric acid (GABA), 10 pM somatostatin, 20 PM basic fibroblast growth factor (bFGF), 50 PM N-methyl-D-aspartate (NMDA) or 40 mM KCl. RNA blot analysis using an Cns-I cDNA probe was accomphshed as described in Figure 3 and Materials and Methods.
these cultured cells to NMDA. Only higher concentrations the chelator EGTA (2.5 mM) reduced cell viability in these cultures (Fig. 11) . All other culture treatments did not reduce cell viability when compared to control cultures ( . NMDA receptor activation increases the synthesis of transcripts from the Cm-1 gene. Cells from the early postnatal cerebellum were cultured for 24 hr in a chemically defined medium containing 5 mM KCl. Cultures were continued for an additional 24 hr in medium containina (+) 10 mM notassium chloride (KU) and 10 UM alvcine (G/v) plus 100 i& amino-5-phosphonovaleric acid (Ah'), or 50 &N-methyl: D-aspartate (NMDA). Nuclei isolated from treated cells were used in a nuclear transcription runoff assay as described in Materials and Methods. RNA probes, synthesized from nuclei in vitro using 32P-UTP, were incubated with a Cns-1 cDNA, an En-2 cDNA, or control plasmid DNA (pGEM 11Z) that had been immobilized to nitrocellulose membranes. Densitometric measurements (OD) of probe hybridization signals were made from autoradiographs in three separate experiments. OD values for hybridization of probes to pGEMl1Z DNA were used as background and subtracted from OD values for hybridization to Cns-I cDNA and En-2 cDNA. The ratio of the OD measurement for Cns-I to the OD measurement for En-2 is presented as the mean + standard error. (acetoxymethy1): Following the pretreatment with either ma& nesium or EGTA, 5b PM N-methyl-D-aspartate (NMDA) was added directly to the culture medium. Following BAPTA pretreatment, the BAPTA containing medium was removed and replaced with fresh medium, minus BAPTA, containing 50 PM NMDA. The cultures were the incubated for an additional 24 hr. RNA blot analysis using an Cns-I cDNA probe was accomplished as described in Figure 3 and Materials and Methods. treatment with 8 mM Mg*+ and 2.5 mM EGTA, these treatment conditions also did not appear to affect morphology of cultures, as examined under phase-contrast microscopy. Thus, cell death induce by the treatment conditions is not likely to account for the response to NMDA or the antagonism of this response by calcium chelators.
Discussion
The amino acid sequence of Cns-1 is similar to the sequence of other POU/homeodomain proteins in the conserved POU-specific domain and homeodomain. Relative amino acid sequence similarity between these proteins in these two conserved domains separates them into five classes (Rosenfeld, 199 1) . There is an 80-98% identity between members of an individual POU/ homeodomain protein class. Cns-1 is at most 57% identical to any other POU/homeodomain protein in these two domains. Thus, Cns-1 appears to belong to a sixth and new class of POU/ homeodomain protein. The POU-specific domain and the homeodomain are involved in sequence specific DNA binding required for these proteins to function as transcriptional activators (Sturm and Herr, 1988; Ingraham et al., 1990) . Outside the POU-specific domain and homeodomain, there are no conserved regions between Cns-1 and other POU/homeodomain proteins. However, Cns-1 contains a region in the amino-terminal half that is similar in amino acid composition to regions in other POU/homeodomain proteins. This region is rich in serine, threonine, and proline residues (Fig. 1) . Regions with similar amino acid composition in Pit-1 and Ott-1 function as transcriptional activation domains (Theill et al., 1989; Ingraham et al., 1990; Tanaka and Herr, 1990 ). Thus, it is possible, given the sequence and structural similarity of Cns-1 with other POU/ homeodomain proteins, that Cns-1 also functions as a tran- acid (APV) was added directly to the culture medium. In the case of cells pretreated with BAPTA, the BAPTA-containing medium was removed and replaced with fresh medium, minus BAPTA, containing 50 PM NMDA. All cultures were the incubated for an additional 24 hr in the presence of NMDA or APV. Cell viability was measured using a trypan blue exclusion assay described in Materials and Methods. Six separate viability measurements were done on cells treated with each condition. The mean percentage of viable cell + standard error is presented for each treatment condition. The viability of cell treated in 2.5 mM EGTA was significantly reduced compared to cell under any other treatment condition (P < 0.01). scriptional activator. However, further studies are necessary to determine definitively whether Cns-1 functions in this manner.
POU/homeodomain and homeodomain proteins are important transcriptional regulators involved in controlling development and determining individual cellular phenotypes (Ingham, 1988; Rosenfeld, 1991; Ruvkun and Finney, 1991) . As a member of the POU/homeodomain protein family, Cns-1 may function similarly in the CNS, a tissue where it is predominantly expressed (Fig. 3) . We have observed that Cm-1 is expressed in reaggregate cultures of cells derived from the early postnatal cerebellum (Fig. 4) . This in vitro preparation of CNS cells consists primarily of cerebellar granule cells but also contains other cerebellar cellular phenotypes including glia (Trenkner and Sidman, 1977; Trenkner, 199 1) . Several aspects of cerebellar granule neuron development may occur in these reaggregate cultures, including cell division of granule neuron precursors (Gao et al., 199 l) , neurite extension, and granule neuron migration (Trenkner and Sidman, 1977). Cm-1 may be expressed in any of the cell types present in these culture and thus may be involved in determining their phenotype (s) . Determination of what cell types express Cns-I must come from experiments to localize its expression within individual cells. We have made an interesting observation concerning expression of Cm-1 in the cerebellar reaggregate cultures. Treatment of these cultures with NMDA at concentrations greater than 10 PM results in an increase in the level of Cm-1 mRNA that is blocked by simultaneous treatment with APV, an NMDA receptor antagonist. We did not observe antagonism of this NMDA response by CNQX, an antagonist of non-NMDA glutamate receptors (Fig. 4A) . Treatment of these cultures with APV alone consistently reduced the level of Cns-I mRNA. Although this was not statistically significant, it is possible that an endogenous activator of the NMDA receptor is present in these cultures. Since granule neurons are glutaminergic and can release glutamate under conditions of tissue culture, it is likely that this endogenous activator is glutamate (Gallo et al., 1982; Van Vliet et al., 1989) . The addition of glycine, a coagonist at the NMDA receptor, might be expected to increase the level of Cns-I mRNA by potentiating the response of NMDA receptors to endogenous glutamate (Johnson and Ascher, 1987) . However, we observed no significant change in the in the level of Cns-I mRNA in response to glycine. In cerebellar slice preparations from the early postnatal cerebellum, endogenous activity of the NMDA receptor on granule neurons is absent unless glycine is present (D'Angelo et al., 1990) . Our reaggregate cultures respond to NMDA at physiologic concentration of KC1 (5 mM) even without added glycine (Fig. 7) . These observations suggest that endogenously release glycine may also be present in these cultures. Variability in the level of Cns-I RNA under control conditions may be the result of variability in the amount of endogenous NMDA receptor agonists present in the cultures. Thus, cultures treated with APV may provide a more accurate measure of the basal level of expression of Cns-I RNA. At resting membrane potentials there is a voltage-dependent Mg*+ block of the NMDA channel (Mayer et al., 1984) . Activation of the channel in the presence of an agonist is dependent on depolarization of the cell that removes the Mg 2+ block. At physiologic K+ our cultures responded to NMDA (Figs. 7, 8 ). This may be due to endogenous glutamate activating non-NMDA glutamate receptors or spontaneous depolarizing activity in the cell providing a depolarizing response to remove the Mg*+ block. Alternatively, this result may be due to a difference in the NMDA receptor's Mg2+ sensitivity in developing neurons (Bowe and Nadler, 1990; Morrisett et al., 1990) . The observation that CNQX did not affect the NMDA-induced increase in Cns-I RNA would suggest that activation of non-NMDA glutamate receptors was not involved in the response. The combined results of these pharmacologic experiments suggest that specific activation of the NMDA subtype of glutamate receptors in cultured cerebellar cells increases the level of Cns-I mRNA. Experiments using several other homeobox genes, En-2, Ott-I, SCIP/Tst-I, and (k-1, suggest that NMDA receptor activation has a relatively specific effect on the level of Cns-I mRNA. Three of these sequences, En-2, Ott-I, and SCIP/Tst-I, have been previously shown to be expressed in the cerebellum He et al., 1989) . Excepting SCZP/Tst-I, NMDA receptor activation did not alter the level of mRNA encoded by these genes (Fig. 8) . However, the response is not limited to the Cns-1 since the level of SCIP/Tst-I RNA also appears to increase in response to NMDA treatment.
An increase in the level of Cns-I mRNA in response to NMDA was first apparent about 2-4 hr after NMDA treatment (Fig.  6B) . The level of Cns-I mRNA reached a new steady state level after about 24 hr of NMDA treatment. This new level was maintained as long as the NMDA receptor remained active. A transcription assay also suggests that, at least in part, this increase in the level of Cns-I mRNA is the result of an increase in transcription from the Cns-I gene (Fig. 9) . The timing of the response would suggest that the synthesis of new genes and their protein products may be require for new Cns-I gene expression. The immediate-early genes may be candidates for regulators of Cns-I expression. Many of these genes are transcription regulators whose expression rapidly increases in the CNS in response to a variety of signals, including NMDA receptor activation (Cole et al., 1989; Szekely et al., 1989; Morgan and Curran, 199 1) . Further experiments will be required to test whether this interaction takes place.
Changes in the level of expression of individual homeobox genes regulate various aspects of development and cellular differentiation (Akam, 1987; Scott and Carroll, 1987; Ingham, 1988) . Similarly, the observed increase in Cns-1 expression may mediate developmental changes of cultured cerebellar cells in response to NMDA receptor activation (Pearce et al., 1987; Balazs et al., 1988a,b; Moran and Patel, 1989; Cox et al., 1990; Cambray-Deakin and Burgoyne, 1992) . This increase in Cns-I expression may occur in granule cells that express functional NMDA receptors (Cull-Candy and Ogden, 1985; Sciancalepore et al., 1989; Cox et al., 1990) or alternatively, granule neuron activation by NMDA could secondarily modify Cns-I expression in other cell types, possibly glia. If the 2.8-3.3-fold increase in the level of Cns-I RNA is occurring in individual cells, is this change large enough to affect cellular differentiation? In Drosophila there are several studies that suggest there is a concentration dependence of homeodomain protein function. The homeodomain protein encoded by bicoid has a critical threshold concentration necessary to activate expression of a second developmental control gene hunchback (Driever and NtissleinVolhard, 1989; Struhl et al., 1989) . As little as a twofold difference in the concentration of the bicoid protein will determine whether hunchback gene expression is on or off (Struhl et al., 1989) . In two loss-of-function mutants the normal two copies of the homeobox genes Ultrabithorax or Sex combed reduced are replaced by only a single copy of the gene. These mutants develop abnormally with a partial transformation of larval segments (Lewis, 1963; Kaufman et al., 1980) . In Drosophila, gene dosage usually determines the concentration of the gene's product. Thus, as little as a twofold change in the level of expression of a homeodomain protein can initiate new gene expression, modifying cellular development and differentiation. Thus, it is possible that this increase in Cns-1 mRNA level could also result in alterations in the differentiation of postnatal cerebellar cells in culture. However, it must first be demonstrated that the increase in Cns-I mRNA results in a comparable increase in the Cns-1 protein and that this increase in Cns-1 protein corresponds to a significant change in developmental gene expression.
Both NMDA and depolarizing concentrations of KC1 have similar effects on the development and differentiation of cerebellar cells in culture (Gallo et al., 1987; Moran and Patel, 1989; Cox et al., 1990) . The response to both these treatments occurs through calcium entry into the cells, either through the NMDA receptor/channel complex or through voltage-dependent L-type calcium channels (Gallo et al., 1987; Moran and Patel, 1989;  
